News & Events

• July 12, 2018
  Hippocampal Volume as an Enrichment Biomarker in Trials of Patients with Mild Cognitive Impairment

• July 12, 2018
  Facilitating rapid data and information sharing by establishing a sustainable, integrated, and standardized platform advancing knowledge to enable expedited drug development

• June 28, 2018
  Parent Project Muscular Dystrophy (PPMD) 2018 Annual Conference

  Jane Larkindale, Executive Director of D-RSC, attended the Parent Project Muscular Dystrophy (PPMD) 2018 Annual Conference in Scottsdale, AZ on June 28 – July 1.  She participated on a panel, Today’s Tomorrow: Looking at the Future and presented two posters: Accelerating drug development: data sharing and developing quantitative tools through the Duchenne Regulatory Science Consortium (D-RSC)......
• April 27, 2018
  Dr. Stephenson’s presentation at University of Texas Health, San Antonio, The Perry and Ruby Stevens Parkinson’s Disease Center of Excellence: “Critical Path for Parkinson’s Collaboration to Enable Patient Focused Drug Development and Precision Medicine”

• March 11, 2018
  D-RSC presents poster on advancing drug development for Duchenne through data sharing and quantitative tool development at the 2018 MDA Clinical Conference